Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
This trial is designed to assess the tolerability and efficacy of simvastatin plus FOLFIRI
(irinotecan, 5-FU, leucovorin) in metastatic colorectal cancer patients.